Welcome to our dedicated page for Claritev SEC filings (Ticker: CTEV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Claritev Corporation filings document a healthcare technology, data and insights issuer with Class A common stock listed on the NYSE under CTEV. Its Form 8-K reports furnish operating results, financial-condition updates, investor presentations and Regulation FD materials tied to its analytics, AI and claims-based healthcare cost-management platform.
Proxy and annual-meeting filings cover board elections, auditor ratification, executive compensation, stockholder votes and amendments to the Claritev Corporation 2020 Omnibus Incentive Plan. Other material-event reports address share-repurchase authorization, capital-structure matters and governance transitions.
Claritev Corp director and CEO Dalton Travis reported a mix of equity award activity and related share disposals on March 1, 2026. He received a grant of 278,925 shares of Class A common stock as a restricted stock unit award, recorded as a grant or other acquisition. To cover tax obligations from vesting of earlier restricted stock units granted on March 1, 2024 and March 1, 2025, 13,806 and 9,824 Class A shares, respectively, were disposed of through tax-withholding transactions at a price of $13.47 per share. In addition, 190,566 cash settled restricted stock units granted on March 1, 2025 were settled in cash upon vesting of 50% of those units, reducing his position in that derivative security. After these transactions, he directly held 498,353 Class A shares and 190,567 cash settled restricted stock units, and there were 24,952 Class A shares held indirectly through his spouse’s individual retirement account.
Claritev Corp executive vice president and chief digital officer Kim Michael reported an open-market purchase of 30,000 shares of Class A common stock on February 27, 2026 at a weighted average price of $14.2985 per share. Following this transaction, Michael directly owns 137,973 shares.
Claritev Corp director and Pres., CEO & Executive Chair Dalton Travis reported an open-market purchase of 15,380 shares of Class A common stock on February 27, 2026. The shares were bought indirectly through his spouse's individual retirement account at a weighted average price of $12.9992 per share. After these transactions, he reported 24,952 shares held indirectly through the spouse’s IRA and 243,058 shares held directly.
Claritev Corp senior vice president and general counsel Tara O'Neil reported an open-market purchase of 750 shares of Class A common stock at a price of $12.99 per share. Following this transaction, her directly held stake increased to 27,199 shares.
Claritev Corporation describes itself as a technology, data and insights company focused on reducing cost, risk and complexity in the U.S. healthcare system. The company serves more than 750 payer clients and estimates its solutions touch over 60 million consumers through 100,000+ plan sponsors.
Claritev reports identifying $25.0 billion in potential savings on $179.8 billion in claim charges in 2025, leveraging a platform that processes about 30 million claims per month and a proprietary network of over 1.4 million contracted providers. It estimates total addressable markets of roughly $10.0 billion for out-of-network cost management, $3.0 billion for in‑network payment and revenue integrity, and $17.0 billion for newer analytics and transparency offerings.
The report outlines the Vision 2030 strategy and notes 2025 was branded “THE TURN,” marking a return to year‑over‑year revenue growth, with 2026 branded “THE WAY UP.” Key risks include dependence on a few large clients, high leverage, intense competition, extensive healthcare regulation and cybersecurity and data‑privacy exposure. As of June 30 2025, non‑affiliate market value was about $505.8 million, and as of February 23 2026, 16,552,723 Class A shares were outstanding.
Claritev Corporation reported Q4 2025 revenue of $246.6 million, up 6.2% from Q4 2024, and narrowed its quarterly net loss to $80.6 million. Adjusted EBITDA for Q4 was $151.3 million with a 61.4% margin, and free cash flow improved to $36.4 million.
For full-year 2025, revenue reached $965.4 million, a 3.7% increase, while the net loss shrank sharply to $284.3 million from $1.65 billion. Full-year Adjusted EBITDA rose to $602.6 million, and operating cash flow was $117.3 million.
The company issued 2026 guidance with revenue between $980 million and $1 billion, Adjusted EBITDA of $605 million to $615 million, capital expenditures of $160 million to $170 million, and free cash flow between $0 million and $10 million. The board also approved a five-year share repurchase program authorizing up to $75 million of Class A common stock, capped at $20 million per year and funded from cash on hand and operations.
Claritev Corp reported that SVP and Chief People Officer Carol Nutter acquired 1,884 shares of Class A common stock through an earned performance-based restricted stock unit (PSU) award. This increased her direct holdings to 30,748 shares.
The PSUs were earned after the Compensation Committee certified that Claritev’s revenue for the two-year performance period ending December 31, 2025 met revenue-based performance criteria. The company’s total revenue versus target resulted in Nutter earning 67% of the originally awarded PSUs. These earned PSUs are scheduled to vest in the first quarter of 2027, subject to her continued employment with Claritev under the 2020 Omnibus Incentive Plan and the applicable PSU award agreement.
Claritev Corp executive vice president and chief digital officer Kim Michael reported an acquisition of 2,444 shares of Class A common stock at $0.0000 per share through a grant/award transaction. These represent earned performance-based restricted stock units tied to the company’s revenue.
The units were earned at 67% of the original performance award after the compensation committee certified revenue-based results for the two-year period ending December 31, 2025. The PSUs are scheduled to vest in the first quarter of 2027, subject to continued employment. Following this award, Michael directly holds 107,973 shares.
Claritev Corp reported that SVP and General Counsel Tara O'Neil acquired 1,421 shares of Class A common stock through an earned grant, not an open-market purchase. The award consists of performance-based restricted stock units that were earned after revenue criteria were met for a two-year period ending December 31, 2025.
These performance stock units are scheduled to vest in the first quarter of 2027, subject to her continued employment with Claritev under the company’s 2020 Omnibus Incentive Plan. Following this award, her directly held Class A common stock totaled 26,449 shares.
Claritev Corp executive vice president and chief operating officer Jerome Hogge reported an equity compensation grant. He acquired 8,723 shares of Class A common stock at a price of $0.00 per share as a grant or award, bringing his direct holdings to 98,746 shares.
The award represents earned performance-based restricted stock units that will vest in the first quarter of 2027, subject to his continued employment. These PSUs were tied to a two-year revenue performance period ending December 31, 2025, with company revenue levels resulting in him earning 67% of the originally awarded units.